ADVOCATE. CONNECT. INNOVATE.

CLSA Wire

Policy Updates
Jun
26
CLSA Statement on Passage of California State Budget

On Tuesday, August 20th, CLSA welcomed a host of lawmakers, legislative staffers, and other key stakeholders to a first of its kind medical device showcase reception in Sacramento.
Category: CLSA HomeCLSA WireSacramento
Jun
24
Preparing for the Next Pandemic White Paper

On Tuesday, August 20th, CLSA welcomed a host of lawmakers, legislative staffers, and other key stakeholders to a first of its kind medical device showcase reception in Sacramento.
Category: CLSA HomeCLSA WirePolicy News
Jun
23
Veto Requested For The Portion Of The State Budget That Affects Biomedical R&D And NOL Tax Credits

On Tuesday, August 20th, CLSA welcomed a host of lawmakers, legislative staffers, and other key stakeholders to a first of its kind medical device showcase reception in Sacramento.
Category: CLSA WireSacramento
Jun
01
California’s Bioeconomy: Opportunities for Leadership

On Tuesday, August 20th, CLSA welcomed a host of lawmakers, legislative staffers, and other key stakeholders to a first of its kind medical device showcase reception in Sacramento.
Category: CLSA HomeCLSA WireSacramento
Feb
25
CLSA State Advocacy in Action

On Tuesday, August 20th, CLSA welcomed a host of lawmakers, legislative staffers, and other key stakeholders to a first of its kind medical device showcase reception in Sacramento.
Category: CLSA HomeCLSA WireSacramento
Jan
27
At Long Last…Repeal of the Medical Device Tax!

On November 18, 2019, as a result of the advocacy of CLSA’s Washington, D.C. based team and the leadership of Congressman Lou Correa (D-Santa Ana), a California Democratic Delegation letter was sent to House Leadership urging swift action to repeal the medical device tax before the end of the year.

Category: CLSA HomeCLSA WireWashington
Dec
17
CLSA Praises House Action to Fully Repeal Medical Device Tax

House overwhelmingly passes year-end spending deal that includes a permanent repeal of the 2.3% medical device tax, Senate likely to approve
Category: CLSA HomeCLSA WirePress ReleasesWashington
Dec
12
CLSA Disappointed by House Passage of H.R. 3, Legislation That Will Short-Circuit Treatments for Patients and California Innovation

CLSA Disappointed by House Passage of H.R. 3, Legislation That Will Short-Circuit Treatments for Patients and California Innovation

Category: CLSA WirePress ReleasesWashington
Dec
09
CLSA Op-Ed in STAT: H.R. 3 is the wrong path to lower drug costs

On Dec. 12, the U.S. House is set to vote on H.R. 3, a bill that will have catastrophic consequences for patients and California’s life sciences sector. Learn why in this STAT News op-ed from CLSA CEO Mike Guerra.

Category: CLSA HomeCLSA WireIn the NewsOp EdWashington
Nov
21
California Democratic Letter To House Leadership In Support Of The Medical Device Tax Repeal

On November 18, 2019, as a result of the advocacy of CLSA’s Washington, D.C. based team and the leadership of Congressman Lou Correa (D-Santa Ana), a California Democratic Delegation letter was sent to House Leadership urging swift action to repeal the medical device tax before the end of the year.

Category: CLSA HomeCLSA WireWashington
MENU